Company: RGNX
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0000950170-25-038770
Chunk: 10

Company: REGENXBIO Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 16
Chunk 10
---
473

    24,790

    Prepaid expenses

    9,067

    14,520

    Other current assets

    13,774

    20,403

    Total current assets

    278,001

    334,971

    Marketable securities

    10,179

    38,871

    Accounts receivable

    474

    701

    Property and equipment, net

    117,589

    132,103

    Operating lease right-of-use assets

    53,716

    60,487

    Restricted cash

    2,030

    2,030

    Other assets

    4,000

    4,807

    Total assets
     
    $
    465,989

    $
    573,970

    Liabilities and Stockholders’ Equity

    Current liabilities

    Accounts payable
     
    $
    22,798

    $
    22,786

    Accrued expenses and other current liabilities

    38,070

    49,703

    Deferred revenue

    115

    148

    Operating lease liabilities

    7,902

    7,068

    Liability related to sale of future royalties

    34,309

    50,567

    Total current liabilities

    103,194

    130,272

    Operating lease liabilities

    74,131

    82,222

    Liability related to sale of future royalties

    25,378

    43,485

    Other liabilities

    3,635

    6,249

    Total liabilities

    206,338

    262,228

    Commitments and contingencies (Note 8)

    Stockholders’ equity

    Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued   and outstanding at December 31, 2024 and 2023

    —

    —

    Common stock; $0.0001 par value; 100,000 shares authorized at December 31, 2024    and 2023; 49,549 and 44,046 shares issued and outstanding at    December 31, 2024 and 2023, respectively

    5